CorMedix
CRMD
187 hedge funds and large institutions have $280M invested in CorMedix in 2026 Q1 according to their latest regulatory filings, with 45 funds opening new positions, 55 increasing their positions, 59 reducing their positions, and 49 closing their positions.
6% more call options, than puts
Call options by funds: $13.8M | Put options by funds: $13M
7% less repeat investments, than reductions
Existing positions increased: 55 | Existing positions reduced: 59
8% less first-time investments, than exits
New positions opened: 45 | Existing positions closed: 49
1.2% less ownership
Funds ownership: 53.24% → 52.04% (-1.2%)
6% less funds holding
Funds holding: 198 → 187 (-11)
43% less capital invested
Capital invested by funds: $488M → $280M (-$208M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RA
Royce & Associates
New York
|
+$12.2M |
| 2 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$7.39M |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$6.67M |
| 4 |
TI
Trexquant Investment
Stamford,
Connecticut
|
+$4.14M |
| 5 |
OAM
Oberweis Asset Management
Lisle,
Illinois
|
+$3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
-$12.9M |
| 2 |
Marshall Wace
London,
United Kingdom
|
-$10.8M |
| 3 |
OE
October Effect
Virginia Beach,
Virginia
|
-$3.56M |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$3.52M |
| 5 |
Swedbank
Stockholm,
Sweden
|
-$2.91M |
CRMD Hedge Fund Activity: Q1 2026 in Review
187 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in CorMedix (CRMD) for Q1 2026, worth a combined $280M — down 43% from $488M a quarter earlier.
Sellers outnumbered buyers: 49 funds closed out of CRMD and 45 opened new positions — a net loss of 4 holders — while 59 trimmed existing stakes and 55 added.
The largest buyer was Royce & Associates, adding an estimated $12.2M. The largest seller was Deerfield Management, exiting entirely with an estimated $12.9M sold.
- 187 institutional investors held CorMedix (CRMD) as of Q1 2026, down from 198 in Q4 2025.
- Funds reported $280M of CorMedix stock for Q1 2026, down 43% quarter-over-quarter.
- 45 funds opened new CorMedix positions in Q1 2026 and 49 closed out, a net change of -4 holders.
- The largest CorMedix buyer in Q1 2026 was Royce & Associates, an estimated $12.2M added.
- The largest CorMedix seller in Q1 2026 was Deerfield Management, an estimated $12.9M sold.
Based on aggregated 13F filings for Q1 2026.